David A. Moreno

8 Patents

• US123515712025

  Substituted Quinoxaline Compounds as Inhibitors of FGFR Tyrosine Kinases

  ARRAY BIOPHARMA Inc.

  0 cites
• US121802072024

  Substituted Pyrazolo[1,5-a]pyridine Compounds as Inhibitors of FGFR Tyrosine Kinases

  Array Biopharma Inc.

  0 cites
• US119985452024

  Substituted Pyrazolo[1,5-a]pyridine Compounds as RET Kinase Inhibitors

  Array Biopharma Inc.

  0 cites
• US119649882024

  Fused Heterocyclic Compounds as RET Kinase Inhibitors

  ARRAY BIOPHARMA Inc.

  0 cites
• US118514342023

  Substituted Pyrazolo[1,5-a]pyrazine Compounds as Ret Kinase Inhibitors

  Array Biopharma Inc.

  0 cites
• US118076512023

  Process for the Preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

  Array Biopharma Inc.

  0 cites
• US116482432023

  Substituted Pyrazolo[1,5-a]pyridine Compounds as RET Kinase Inhibitors

  Array Biopharma Inc.

  0 cites
• US116033742023

  Substituted Pyrrolo[2,3-d]pyrimidines Compounds as Ret Kinase Inhibitors

  Array Biopharma Inc.

  0 cites